Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration

por Clark, Andrew R., Ohlmeyer, Michael
Publicado 2019

Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases

por Yu, Howard, Zaveri, Sahil, Sattar, Zeeshan, Schaible, Michael, Perez Gandara, Brais, Uddin, Anwar, McGarvey, Lucas R., Ohlmeyer, Michael, Geraghty, Patrick
Publicado 2023

Inhibitor of CBP Histone Acetyltransferase Downregulates p53 Activation and Facilitates Methylation at Lysine 27 on Histone H3

por Vincek, Adam S., Patel, Jigneshkumar, Jaganathan, Anbalagan, Green, Antonia, Pierre-Louis, Valerie, Arora, Vimal, Rehmann, Jill, Mezei, Mihaly, Zhou, Ming-Ming, Ohlmeyer, Michael, Mujtaba, Shiraz
Publicado 2018

Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells

por Denisova, Oxana V., Merisaari, Joni, Kaur, Amanpreet, Yetukuri, Laxman, Jumppanen, Mikael, von Schantz-Fant, Carina, Ohlmeyer, Michael, Wennerberg, Krister, Aittokallio, Tero, Taipale, Mikko, Westermarck, Jukka
Publicado 2022

γ-H2AX Kinetics as a Novel Approach to High Content Screening for Small Molecule Radiosensitizers

por Fu, Shibo, Yang, Ying, Tirtha, Das, Yen, Yun, Zhou, Bing-sen, Zhou, Ming-Ming, Ohlmeyer, Michael, Ko, Eric C., Cagan, Ross, Rosenstein, Barry S., Chen, Shu-hsia, Kao, Johnny
Publicado 2012

Correction: γ-H2AX Kinetics as a Novel Approach to High Content Screening for Small Molecule Radiosensitizers

por Fu, Shibo, Yang, Ying, Das, Tirtha K., Yen, Yun, Zhou, Bing-sen, Zhou, Ming-Ming, Ohlmeyer, Michael, Ko, Eric C., Cagan, Ross, Rosenstein, Barry S., Chen, Shu-hsia, Kao, Johnny
Publicado 2012

Monotherapy efficacy of blood–brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma

por Merisaari, Joni, Denisova, Oxana V, Doroszko, Milena, Le Joncour, Vadim, Johansson, Patrik, Leenders, William P J, Kastrinsky, David B, Zaware, Nilesh, Narla, Goutham, Laakkonen, Pirjo, Nelander, Sven, Ohlmeyer, Michael, Westermarck, Jukka
Publicado 2020

TBK1 and IKKε act like an OFF switch to limit NLRP3 inflammasome pathway activation

por Fischer, Fabian A., Mies, Linda F. M., Nizami, Sohaib, Pantazi, Eirini, Danielli, Sara, Demarco, Benjamin, Ohlmeyer, Michael, Lee, Michelle Sue Jann, Coban, Cevayir, Kagan, Jonathan C., Di Daniel, Elena, Bezbradica, Jelena S.
Publicado 2021

Rapid Characterization of Solid Tumors Using Resonant Sensors

por Beierle, Andee M., Quinn, Colin H., Markert, Hooper R., Carr, Adam, Marayati, Raoud, Bownes, Laura V., Hutchins, Sara Claire, Stewart, Jerry E., Hill, Benjamin, Ohlmeyer, Michael, Reuel, Nigel F., Beierle, Elizabeth A.
Publicado 2022

PP2A‐based triple‐strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells

por Denisova, Oxana V., Merisaari, Joni, Huhtaniemi, Riikka, Qiao, Xi, Yetukuri, Laxman, Jumppanen, Mikael, Kaur, Amanpreet, Pääkkönen, Mirva, von Schantz‐Fant, Сarina, Ohlmeyer, Michael, Wennerberg, Krister, Kauko, Otto, Koch, Raphael, Aittokallio, Tero, Taipale, Mikko, Westermarck, Jukka
Publicado 2023

Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma

por Bownes, Laura V., Marayati, Raoud, Quinn, Colin H., Beierle, Andee M., Hutchins, Sara C., Julson, Janet R., Erwin, Michael H., Stewart, Jerry E., Mroczek-Musulman, Elizabeth, Ohlmeyer, Michael, Aye, Jamie M., Yoon, Karina J., Beierle, Elizabeth A.
Publicado 2022

Control of Embryonic Stem Cell Identity by BRD4-Dependent Transcriptional Elongation of Super-Enhancer-Associated Pluripotency Genes

por Micco, Raffaella Di, Fontanals-Cirera, Barbara, Low, Vivien, Ntziachristos, Panagiotis, Yuen, Stephanie K., Lovell, Claudia D., Dolgalev, Igor, Yonekubo, Yoshiya, Zhang, Guangtao, Rusinova, Elena, Gerona-Navarro, Guillermo, Cañamero, Marta, Ohlmeyer, Michael, Aifantis, Iannis, Zhou, Ming-Ming, Tsirigos, Aristotelis, Hernando, Eva
Publicado 2014